Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/13803
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVAN DER SPEETEN, Kurt-
dc.contributor.authorGovaerts, K.-
dc.contributor.authorStuart, O. A.-
dc.contributor.authorSugarbaker, P. H.-
dc.date.accessioned2012-07-17T07:49:17Z-
dc.date.available2012-07-17T07:49:17Z-
dc.date.issued2012-
dc.identifier.citationGASTROENTEROLOGY RESEARCH AND PRACTICE, 2012 (Article ID 378064)-
dc.identifier.issn1687-6121-
dc.identifier.urihttp://hdl.handle.net/1942/13803-
dc.description.abstractBackground. The peritoneal surface is an acknowledged locoregional failure site of abdominal malignancies. Previous treatment attempts with medical therapy alone did not result in long-term survival. During the last two decades, new treatment protocols combining cytoreductive surgery with perioperative intraperitoneal and intravenous cancer chemotherapy have demonstrated very encouraging clinical results. This paper aims to clarify the pharmacologic base underlying these treatment regimens. Materials and Methods. A review of the current pharmacologic data regarding these perioperative chemotherapy protocols was undertaken. Conclusions. There is a clear pharmacokinetic and pharmacodynamic rationale for perioperative intraperitoneal and intravenous cancer chemotherapy in peritoneal surface malignancy patients.-
dc.language.isoen-
dc.publisherHINDAWI PUBLISHING CORPORATION-
dc.subject.otherGastroenterology & Hepatology-
dc.titlePharmacokinetics of the Perioperative Use of Cancer Chemotherapy in Peritoneal Surface Malignancy Patients-
dc.typeJournal Contribution-
dc.identifier.issueArticle ID 378064-
dc.identifier.volume2012-
local.format.pages9-
local.bibliographicCitation.jcatA1-
dc.description.notes[Van der Speeten, K.; Govaerts, K.] Oost Limburg Hosp, Dept Surg Oncol, B-3600 Genk, Belgium. [Van der Speeten, K.] Univ Hasselt, Fac Med, Dept Biochem, B-3590 Diepenbeek, Belgium. [Van der Speeten, K.; Stuart, O. A.; Sugarbaker, P. H.] Washington Hosp Ctr, Washington Canc Inst, Washington, DC 20010 USA.-
local.publisher.placeNEW YORK-
local.type.refereedRefereed-
local.type.specifiedReview-
dc.bibliographicCitation.oldjcatA1-
dc.identifier.doi10.1155/2012/378064-
dc.identifier.isi000305653300001-
item.fulltextWith Fulltext-
item.validationecoom 2013-
item.accessRightsOpen Access-
item.fullcitationVAN DER SPEETEN, Kurt; Govaerts, K.; Stuart, O. A. & Sugarbaker, P. H. (2012) Pharmacokinetics of the Perioperative Use of Cancer Chemotherapy in Peritoneal Surface Malignancy Patients. In: GASTROENTEROLOGY RESEARCH AND PRACTICE, 2012 (Article ID 378064).-
crisitem.journal.issn1687-6121-
crisitem.journal.eissn1687-630X-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
van der speeten 1.pdfarticle611.74 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

15
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

13
checked on Jun 21, 2022

Page view(s)

62
checked on Jun 24, 2022

Download(s)

96
checked on Jun 24, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.